Part detail
Dexbrompheniramine Maleate And Pseudoephedrine Sulfate Extended Release Tablets
1087NSN6505-01-281-3557CAGE53300
Dexbrompheniramine Maleate And Pseudoephedrine Sulfate Extended Release Tablets
Detailed description
1087 procurement notes
Dexbrompheniramine Maleate And Pseudoephedrine Sulfate Extended Release Tablets
Specifications
Reference data
Multi-line procurement
Sourcing more than one part?
Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.
Compliance
- AS9120:2025· Aerospace QMS
- ISO 9001:2015· Quality Management
- FAA AC 00-56B· Voluntary Industry Distributor Accreditation
- U.S. ONLY· Fulfillment
Characteristics Data of NSN 6505-01-281-3557, 6505012813557
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 6.000 MILLIGRAMS DEXBROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 120.000 MILLIGRAMS PSEUDOEPHEDRINE SULFATE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| FEAT | SPECIAL FEATURES | LONG ACTION METHOD:EXTENDED RELEASE; |